Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

0.7349 +0.0249 (+3.51%)
Streaming Delayed Price Updated: 2:11 PM EDT, Apr 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
33 34 Next >
24 Stocks Moving in Thursday's Pre-Market Session
Gainers Evaxion Biotech A/S (NASDAQ: EVAX) rose 143.5% to $15.83 in pre-market trading after dropping over 10% on Wednesday. TDH Holdings, Inc. (NASDAQ: PETZ) rose 72.6% to $4.09... 
Via Benzinga
86 Biggest Movers From Yesterday
Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million.... 
Via Benzinga
Ocugen Neared $16 Yesterday, But I’ll Eat 4 Hats If It Gets to $32
OCGN stock has moved higher despite little evidence anything’s changed regarding Ocugen’s revenue potential in the U.S. 
Via InvestorPlace
Exposures COVID-19
Most Active Equity Options For Midday - Wednesday, Nov. 3
Top Tickers: TSLA, AMC, AMD, AAPL, F, BBBY, LCID, GME, BB, NVDA, Z, UBER, PLTR, HOOD, OCGN, AAL, ATVI, SOFI, PFE, FB. 
Via Talk Markets
Why Ocugen Stock Is Falling Today
The biotech received some good news for its most important product. So why is the stock down? 
Via The Motley Fool
Exposures COVID-19
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers iRhythm Technologies (NASDAQ:IRTC) stock moved upwards by 52.78% to $117.34 during Wednesday's regular session. iRhythm Technologies's stock is trading at... 
Via Benzinga
BZ Chart Of The Day: Will Ocugen Remember?
They say that markets have memories. It’s true, and holders and traders of Ocugen, Inc. (NASDAQ: 
Via Benzinga
Ocugen's India Partnered COVID-19 Vaccine Gets WHO Approval: Report
WHO's Technical Advisory Group has recommended the Emergency Use Listing status for Bharat Biotech's COVID-19, Covaxin. Read Next: Ocugen Reverses Course From Monday... 
Via Benzinga
Exposures COVID-19
Here's Why Ocugen Stock Skyrocketed 64.9% in October
The biotech stock is now up a staggering 756% year to date. 
Via The Motley Fool
Exposures COVID-19
OCGN Stock Alert: WHO Issues Emergency-Use Listing for Covaxin
The WHO has finally given Covaxin emergency approval, putting OCGN stock in the spotlight. Will Ocugen be able to bring doses to the U.S.? 
Via InvestorPlace
Exposures COVID-19
3 Explosive Biotech Stocks -- Could They Shoot Even Higher?
These biotech stocks have recently been responsible for a slew of rocketship emojis. 
Via The Motley Fool
PFE Stock Alert: 3 Catalysts Giving Pfizer Stock a Shot in the Arm Today
Pfizer is getting ready to start shipping children's vaccines, and PFE stock is rising. That's not the only good news for investors, though. 
Via InvestorPlace
OCGN Stock Alert: Why Ocugen Shares Are Drawing Eyes Ahead of Nov. 3
A key WHO ruling that could materialize as soon as tomorrow has investors considering where OCGN stock could be headed this week. 
Via InvestorPlace
Exposures COVID-19
Check Out What Whales Are Doing With OCGN
Someone with a lot of money to spend (and possibly insider knowledge) has taken a bearish stance on Ocugen (NASDAQ:OCGN). And retail traders should know. We noticed this today... 
Via Benzinga
An Approval by WHO Would Not Help Ocugen
Ocugen is forging ahead with its plans for regulatory approval, but that doesn't make OCGN stock any more worthy of your capital. 
Via InvestorPlace
Exposures Product Safety
Why Ocugen Stock Will Probably Soar Tomorrow -- but Shouldn't
Investors are excited about a decision that doesn't really benefit Ocugen at this point. 
Via The Motley Fool
Exposures COVID-19
64 Biggest Movers From Yesterday
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on... 
Via Benzinga
What's Going On With Ocugen's Stock?
Ocugen, Inc. (NASDAQ: OCGN) shares are trading higher amid heightened interest in the stock from retail traders on social media. According to SwaggyStocks, Ocugen was the fifth... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's regular session. As of 12:30 EST, this security is trading at a volume... 
Via Benzinga
40 Stocks Moving In Monday's Mid-Day Session
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares jumped 250% to $8.91 on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the... 
Via Benzinga
Better Therapeutics SPAC Merger: 8 Things for BTTX Stock Investors to Know
Better Therapeutics (BTTX) stock is surging higher on Monday after completing its SPAC merger with Mountain Crest Acquisition Corp II. 
Via InvestorPlace
ABVC Stock: The Social Media Chatter That Has ABVC BioPharma Shooting 250% Higher Today
ABVC BioPharma (ABVC) stock is rocketing higher on Monday as investors on social media hype up the shares despite a lack of news. 
Via InvestorPlace
OCGN Stock Alert: This Covaxin Update Is Sending Ocugen Rallying
Australia just gave a vote of confidence to Covaxin, sending OCGN stock climbing. However, the real catalyst rests in the hands of the WHO. 
Via InvestorPlace
Exposures COVID-19
2 Best Biotech Stocks to Buy in November
Bionano Genomics and Ocugen could both be gearing up for a healthy rally this month. 
Via The Motley Fool
28 Stocks Moving in Monday's Pre-Market Session
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) rose 333.9% to $11.02 in pre-market trading. ABVC Biopharma’s S-3 showed registration for $50 million mixed securities shelf... 
Via Benzinga
4 Reasons Why Ocugen Will Make Very Little or No Money From Covaxin
Ocuigen is unlikely to be able to get Covaxin widely distributed in the U.S. until Spring 2023. By that time, it won't help OCGN stock much. 
Via InvestorPlace
Exposures COVID-19 Product Safety
5 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Bio-Path Holdings (NASDAQ:BPTH) shares moved upwards by 9.69% to $5.43 during Wednesday's pre-market session. The company's market cap stands at $37.7... 
Via Benzinga
Tesla Remains Top WallStreetBets Interest; AMD, Ocugen, Facebook And These Are Other Top Trends Today
Tesla Inc. (NASDAQ:TSLA) continued to be the most-discusse... 
Via Benzinga
Ocugen Reverses Course From Monday's Massive Surge As COVID-19 Vaccine Partner Faces WHO Setback
Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) fell 2% in Tuesday’s regular trading session after seeing strong gains on Monday. What Happened: Ocugen’... 
Via Benzinga
Exposures COVID-19
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.